DULOXETINE HYDROCHLORIDE
NDC 50771-203, DULOXETINE HYDROCHLORIDE, capsule, delayed release pellets, from Yaopharma Co., Ltd..
- Product NDC
- 50771-203
- Status
- Listed
- Labeler
- Yaopharma Co., Ltd.
- Dosage form
- CAPSULE, DELAYED RELEASE PELLETS
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207219
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50771-203 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DULOXETINE HYDROCHLORIDE60 mg/1
Pharmacologic classes
Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50771-203-01 | 50771020301 | 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (50771-203-01) |
| 50771-203-02 | 50771020302 | 500 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (50771-203-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/90224073-178d-7ec5-e053-2995a90a20fc
Use it
Look up 50771-203 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50771-203 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50771-203. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.